Rallybio Corp
RLYB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739410
No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Rallybio Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 58 | 0 |
| Shares | 33.3M | 1.73M | 31.2M | −330.6K (−1.0%) |
| Value | $188.3M | $9.78M | $105.2M | −$73.3M (−41.1%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Rallybio Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Financial Security Advisor, Inc. | 50,278 | $169.4K | 0.08% |
| Squarepoint Ops LLC | 10,197 | $34.4K | 0.00% |
| Capstone Investment Advisors, LLC | 10,000 | $33.7K | 0.00% |
| Nisa Investment Advisors, LLC | 1,399 | $4.71K | 0.00% |
| Federated Hermes, Inc. | 45 | $152 | 0.00% |
Sold out (5)
Institutions that held Rallybio Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Caas Capital Management LP | 31,470 | $178.1K |
| Price T Rowe Associates Inc | 12,770 | $74.0K |
| Millennium Management LLC | 10,141 | $57.4K |
| Allspring Global Investments Holdings, LLC | 465 | $2.63K |
| Russell Investments Group, Ltd. | 273 | $1.54K |
Not filed for Q3 2023 yet (1)
Institutions that held Rallybio Corp at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 1,727,067 | $9.78M |